Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Breast tumour stroma is a prognostic indicator and target for therapy.

    Howell A, Landberg G, Bergh J.

    Breast Cancer Res. 2009;11 Suppl 3:S16. Epub 2009 Dec 18. No abstract available.

    PMID:
    20030867
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.

    Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, André S, Piccart M, Campone M, Brain E, Macgrogan G, Petit T, Jassem J, Bibeau F, Blot E, Bogaerts J, Aguet M, Bergh J, Iggo R, Delorenzi M.

    Nat Med. 2009 Jan;15(1):68-74. Epub 2009 Jan 4. Erratum in: Nat Med. 2009 Feb;15(2):220. Wirapati, Pratyakasha [corrected to Wirapati, Pratyaksha].

    PMID:
    19122658
    [PubMed - indexed for MEDLINE]
    3.

    The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

    Hildenbrand R, Schaaf A.

    Int J Oncol. 2009 Jan;34(1):15-23.

    PMID:
    19082473
    [PubMed - indexed for MEDLINE]
    4.

    Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

    Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.

    Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.

    PMID:
    16244790
    [PubMed - indexed for MEDLINE]
    5.

    Development and validation of gene expression profile signatures in early-stage breast cancer.

    Desmedt C, Sotiriou C, Piccart-Gebhart MJ.

    Cancer Invest. 2009 Jan;27(1):1-10. Review. No abstract available.

    PMID:
    19191098
    [PubMed - indexed for MEDLINE]
    6.

    Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy.

    Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, Bonuccelli G, Jasmin JF, Frank PG, Pestell RG, Kleer CG, Sotgia F, Lisanti MP.

    Cell Cycle. 2009 Jun 1;8(11):1654-8.

    PMID:
    19448435
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

    Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

    Zentralbl Gynakol. 2006 Apr;128(2):76-81.

    PMID:
    16673249
    [PubMed - indexed for MEDLINE]
    8.

    Differential gene expression in breast cancer cell lines and stroma-tumor differences in microdissected breast cancer biopsies revealed by display array analysis.

    Mellick AS, Day CJ, Weinstein SR, Griffiths LR, Morrison NA.

    Int J Cancer. 2002 Jul 10;100(2):172-80.

    PMID:
    12115566
    [PubMed - indexed for MEDLINE]
    9.

    HER2 signatures in breast cancer: ready to go to print?

    Eichhorn PJ, Baselga J.

    J Clin Oncol. 2010 Apr 10;28(11):1809-10. Epub 2010 Mar 15. No abstract available.

    PMID:
    20231675
    [PubMed - indexed for MEDLINE]
    10.

    Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancer.

    Kim DH, Yoon DS, Dooley WC, Nam ES, Ryu JW, Jung KC, Park HR, Sohn JH, Shin HS, Park YE.

    Histopathology. 2003 Jan;42(1):37-42.

    PMID:
    12493023
    [PubMed - indexed for MEDLINE]
    11.

    Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.

    Hildenbrand R, Schaaf A, Dorn-Beineke A, Allgayer H, Sütterlin M, Marx A, Stroebel P.

    Histol Histopathol. 2009 Jul;24(7):869-77.

    PMID:
    19475533
    [PubMed - indexed for MEDLINE]
    12.

    Gene expression profiling of the tumor microenvironment during breast cancer progression.

    Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC.

    Breast Cancer Res. 2009;11(1):R7. Epub 2009 Feb 2.

    PMID:
    19187537
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers.

    Surowiak P, Suchocki S, Györffy B, Gansukh T, Wojnar A, Maciejczyk A, Pudełko M, Zabel M.

    Folia Histochem Cytobiol. 2006;44(2):111-6.

    PMID:
    16805136
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Stromal gene expression predicts clinical outcome in breast cancer.

    Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M.

    Nat Med. 2008 May;14(5):518-27. Epub 2008 Apr 27.

    PMID:
    18438415
    [PubMed - indexed for MEDLINE]
    16.

    Gene expression profiling of breast cancer: a new tumor marker.

    van't Veer LJ, Paik S, Hayes DF.

    J Clin Oncol. 2005 Mar 10;23(8):1631-5. Review. No abstract available.

    PMID:
    15755970
    [PubMed - indexed for MEDLINE]
    17.

    Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.

    Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M, Gaboury L, Siegel PM.

    Clin Cancer Res. 2010 Apr 1;16(7):2147-56. Epub 2010 Mar 9.

    PMID:
    20215530
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.

    Ray PS, Wang J, Qu Y, Sim MS, Shamonki J, Bagaria SP, Ye X, Liu B, Elashoff D, Hoon DS, Walter MA, Martens JW, Richardson AL, Giuliano AE, Cui X.

    Cancer Res. 2010 May 15;70(10):3870-6. Epub 2010 Apr 20.

    PMID:
    20406990
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Hypoxia and breast cancer: prognostic and therapeutic implications.

    Lundgren K, Holm C, Landberg G.

    Cell Mol Life Sci. 2007 Dec;64(24):3233-47. Review.

    PMID:
    17957335
    [PubMed - indexed for MEDLINE]
    20.

    MMP13 is potentially a new tumor marker for breast cancer diagnosis.

    Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR.

    Oncol Rep. 2009 Nov;22(5):1119-27.

    PMID:
    19787229
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk